The PPARγ2 Pro12Ala variant predicts ESRD and mortality in patients with type 1 diabetes and diabetic nephropathy (Q57737184)

2

0 references

Torben Hansen

object named as

T. Hansen

5

0 references

Oluf Borbye Pedersen

object named as

O. Pedersen

6

0 references

author name string

M. Lajer

3

0 references

J. Ek

4

0 references

H.-H. Parving

Molecular Genetics and Metabolism

7

0 references

publication date

July 2008

0 references

published in

0 references

volume

94

0 references

issue

3

0 references

page(s)

347-351

0 references

cites work

The effect of proteinuria on relative mortality in type 1 (insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.03.014

Major susceptibility locus for nephropathy in type 1 diabetes on chromosome 3q: results of novel discordant sib-pair analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.03.014

Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes. Pima Diabetes Genes Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.03.014

PPAR-gamma: adipogenic regulator and thiazolidinedione receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.03.014

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.03.014

Protection of the kidney by thiazolidinediones: an assessment from bench to bedside

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.03.014

Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor gamma (PPARgamma). Differential activity of PPARgamma1 and -2 isoforms and influence of insulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.03.014

A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.03.014

Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.03.014

Cardiovascular risk in type 2 diabetes is associated with variation at the PPARG locus: a Go-DARTS study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.03.014

Peroxisome proliferator-activated receptor-gamma2 polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: The Berlin Diabetes Mellitus (BeDiaM) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.03.014

The human peroxisome proliferator-activated receptor gamma2 (PPARgamma2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.03.014

Analysis of the type 2 diabetes-associated single nucleotide polymorphisms in the genes IRS1, KCNJ11, and PPARG2 in type 1 diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.03.014

IRS1, KCNJ11, PPARgamma2 and HNF-1alpha: do amino acid polymorphisms in these candidate genes support a shared aetiology between type 1 and type 2 diabetes?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.03.014

Aldosterone synthase (CYP11B2) -344T/C polymorphism is not associated with the initiation and progression of diabetic nephropathy in Caucasian Type 1 diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.03.014

Analysis of 14 Candidate Genes for Diabetic Nephropathy on Chromosome 3q in European Populations: Strongest Evidence for Association With a Variant in the Promoter Region of the Adiponectin Gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.03.014

Enzyme immunoassay: an improved determination of urinary albumin in diabetics with incipient nephropathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.03.014

Effect of deletion polymorphism of angiotensin converting enzyme gene on progression of diabetic nephropathy during inhibition of angiotensin converting enzyme: observational follow up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.03.014

Homozygosity of the Pro12Ala variant of the peroxisome proliferation-activated receptor-gamma2 (PPAR-gamma2): divergent modulating effects on body mass index in obese and lean Caucasian men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.03.014

Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) gene in relation to insulin sensitivity among glucose tolerant caucasians

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.03.014

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.03.014

Association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma with Pre-diabetic phenotypes: meta-analysis of 57 studies on nondiabetic individuals.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.03.014

Causes of albuminuria in patients with type 2 diabetes without diabetic retinopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.03.014

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.03.014

Association between Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma 2 and myocardial infarction in the Chinese Han population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.03.014

Alanine for proline substitution in the peroxisome proliferator-activated receptor gamma-2 (PPARG2) gene and the risk of incident myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2008.03.014